News About: Pharm. Industry
This year’s business key words, “overseas expansion and new drug development” in pharma industry
It was analyzed pharmaceutical and biotechnological companies have set their management keyword to ‘overseas expansion’ and ‘new drug development’ this year.
According to the analysis result of major pharmaceutical a...
Listed pharmas’ cash dividends less than the last year
This year, listed pharmaceutical companies were analyzed to have cash dividends less than the last year.
It was told some of the pharmaceutical companies have not decided availability of cash dividends yet despite th...
Rep. Do-Ja Choi “Government employees handling drug approval must be restricted in stock trading”
An opinion was suggested that employees concerned to drug and biologic approval must be restricted in stock trading.
People’s Party Rep. Do-Ja Choi made the request to the Ministry of Food and Drug Safety(MFDS) at th...
Korea United Pharm’s Vietnamese PIC/s GMP certification through ‘public-private’ cooperation
As generating the first outcome after Korea joined in the PIC/s(Pharmaceutical Inspection Co-operation Scheme), the pharmaceutical industry has raised an expectation of having similar outcomes in the future. Since it ...
KoreaBio reappointed President Jeong-Sun Seo and Chairman Byung-Gun Lee
The Korea Biotechnology Industry Organization(President Jeong-Sun Seo, hereinafter referring to KoreaBio) has decided reappointment of President Jeong-Sun Seo and Chairman Byung-Gun Lee in the 5th Presidents’ Board in...
KPMA appoints former Rep. Hee-Mok Won as next chairman
As the next chairman of the Korea Pharmaceutical Manufacturers Association(KPMA), Hee-Mok Won, a former representative of the National Assembly, was appointed. Moreover, 3 people(Daewon Pharm Chairman Seung-Ho Baek, A...
What will change in pharma industry after change of chairman?
The Korea Pharmaceutical Manufacturers Association(KPMA) elected Mr. Hee-Mok Won as the next Chairman at the board meeting on the 15th and elected 3 more people in the Vice Chairmen’s Board.
They dealt various items ...
Merck signs co-promotion agreement of ‘Glucophage & Concor’ with Yungjin Pharm
The Merck Korea’s biopharma department, a Korean subsidiary of Merck, signed a Korean co-promotion agreement of the primary treatment for diabetes type 2 ‘Glucophage/ Glucophage XR’ and the selective beta blocker ‘Con...
Gilead-Yuhan hold Korean ‘Genvoya’ Launch Event
Gilead Sciences Korea(CEO Seung-Woo Lee) and Yuhan Corporation(CEO Jung-Hee Lee) announced that they held the product launch event for the new one-pill, combination HIV treatment ‘Genvoya(elvitegravir 150mg, cobicista...
Prosecution starts investigation on other pharmas derived from Novartis’s rebate investigation
The prosecution has started the countdown for an investigation on pharmaceutical companies that were newly exposed from the rebate investigation on the multinational pharmaceutical company Novartis Korea.
According t...
